With Moderna already eyeing the latest emerging diseases, will you be jumping on MRNA stock? Amgen is a biotech company that develops and delivers innovative human therapeutics. It uses tools like ...

On Stocktwits, Portage Biotech shares were among the top 10 trending symbols by 10 AM ET. A poll on the platform revealed ...

UK-based biotechnology company developing targeted therapies. Astex Pharmaceuticals, Inc. is expected to begin trading on NASDAQ under the symbol ASTX on September 12, 2011. Astex Therapeutics ...

A less-risky approach to biotech is to invest in large-cap biopharma stocks. These two companies saw corporate insiders recently buying stock. Pfizer Inc. (PFE): Pfizer’s size and strong balance ...

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism ...

Detailed price information for Kane Biotech Inc (KNE-X) from The Globe and Mail including charting and trades.

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...

Its pipeline looks especially promising. The company's business is highly resilient. Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk.

But biotech companies vary more than most in other industries. Some have no hopes of ever making money. And others are backed by products that are established in the marketplace and are quite ...